-
Moderna Gets Another $472M Federal Funding For Late-Stage Coronavirus Vaccine Development
Sunday, July 26, 2020 - 10:38pm | 445Read More...Moderna Inc. (NASDAQ: MRNA) announced Sunday it is receiving another $472 million funding from President Donald Trump's administration to support late-stage clinical development of its coronavirus vaccine candidate, including an expanded phase 3 study. What Happened The Cambridge...
-
NewLink Genetics Surges 3% Following Ebola Contract News
Monday, December 22, 2014 - 10:32am | 175Read More...NewLink Genetics Corp (NASDAQ: NLNK) and Merck & Co., Inc. (NYSE: MRK) on Monday announced a contract for development of an Ebola vaccine. According to the press release, the Biomedical Advanced Research and Development Authority (BARDA) of the United States Department of Health and Human...
